Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02107235
Title Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Onconova Therapeutics, Inc.

oropharynx cancer

laryngeal squamous cell carcinoma

hypopharynx cancer

head and neck cancer



Rigosertib Sodium

Age Groups: adult
Covered Countries USA

No variant requirements are available.